minoxidil
Sponsor SBFM · listed as SBFM
READOUT
Phase 3
Confidence: medium
Source: clinicaltrials
minoxidil is a clinical-stage drug asset sponsored by SBFM, listed as SBFM. CSA tracks 1 forward catalyst for it — the nearest is a readout expected Oct 2026 (month precision, medium confidence), tied to trial NCT05888922. The asset is in Phase 3 and currently recruiting, studied in Androgenetic Alopecia. It appears across 5 tracked trials in the CSA sample.
Next catalyst
Event typeREADOUT
Expected date2026-10-31
As disclosedOct 2026
Date precisionmonth
Confidencemedium
Trial & sponsor
Trial (NCT)NCT05888922
PhasePHASE3
StatusRECRUITING
Lead sponsorIndustrial Farmacéutica Cantabria, S.A.
Listed asSBFM
Condition(s)Androgenetic Alopecia; Female Pattern Baldness
!
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.
Get the full dataset — $499 → More SBFM catalysts